Boston Common Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.85M | Sell |
69,343
-2,375
| -3% | -$166K | 0.14% | 198 |
|
|
2025
Q1 | $5.27M | Buy |
71,718
+16,608
| +30% | +$1.22M | 0.16% | 177 |
|
|
2024
Q4 | $3.61M | Sell |
55,110
-7,855
| -12% | -$515K | 0.11% | 207 |
|
|
2024
Q3 | $4.91M | Sell |
62,965
-3,263
| -5% | -$254K | 0.13% | 194 |
|
|
2024
Q2 | $5.17M | Sell |
66,228
-2,474
| -4% | -$193K | 0.13% | 182 |
|
|
2024
Q1 | $4.66M | Buy |
68,702
+1,177
| +2% | +$79.7K | 0.11% | 202 |
|
|
2023
Q4 | $4.55M | Sell |
67,525
-6,089
| -8% | -$410K | 0.1% | 210 |
|
|
2023
Q3 | $4.99M | Sell |
73,614
-2,164
| -3% | -$147K | 0.12% | 196 |
|
|
2023
Q2 | $5.42M | Buy |
75,778
+2,074
| +3% | +$148K | 0.12% | 196 |
|
|
2023
Q1 | $5.12M | Buy |
73,704
+7,313
| +11% | +$508K | 0.11% | 204 |
|
|
2022
Q4 | $4.5M | Buy |
66,391
+13,369
| +25% | +$906K | 0.22% | 110 |
|
|
2022
Q3 | $2.91M | Buy |
53,022
+14,364
| +37% | +$788K | 0.15% | 134 |
|
|
2022
Q2 | $2.55M | Buy |
+38,658
| New | +$2.55M | 0.13% | 145 |
|